Vizient Pharmacy Market Outlook – Summer 2024

Vizient publishes our Pharmacy Market Outlook twice a year. The outlook features drug price projections and key market insights to help support members' strategic planning. Drs. Jeni Hayes and Amanda Frick, both Senior Clinical Managers for Market Intelligence, join Carolyn Liptak, Pharmacy Executive Director in the Vizient Center for Pharmacy Practice Excellence and your program host to give an early look.

 

Guest speakers: 
Jeni Hayes, PharmD, MSPharm, BCPS
Senior Clinical Manager, Market Intelligence
Vizient 

 

Amanda Frick, PharmD, BCPS
Senior Clinical Manager, Market Intelligence
Vizient

 

Host: 
Carolyn Liptak, MBA, BS Pharm 
Pharmacy Executive Director 
Vizient Center for Pharmacy Practice Excellence 

 

Show Notes: 

[00:45-02:06] Hot Topics 2024 highlighted in this Pharmacy Market Outlook 

[02:07-02:50] Pipeline section looks different. What are the updates?

[02:51-03:44] Looking forward to drugs being approved in 2024: afami-cel and obi-cel

[03:45-4:45] New and noteworthy medication approvals

[4:46 – 5:55] Cell and gene therapy agents

[5:56-10:32] Therapeutic area updates

[6:45] Autoimmune and inflammatory

[7:16] Cardiopulmonary

[7:51] Endocrine and metabolic

[8:05] Hematological agents

[8:26] Infectious diseases

[8:47] Neurology

[9:10] Oncology

[10:06] Plasma

[10:33 -11:29] What's the projection for this edition

[11:30-12:08] Where listeners go if they want more detailed information on the outlook

 

Links | Resources: 

Vizient Pharmacy Market Outlook provider link: Click Here

Vizient Pharmacy Market Outlook highlights public version: Click Here

 

Subscribe Today!

Apple Podcasts

Amazon Podcasts

Spotify

Android

RSS Feed